APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON MAY 11, 2023By ApyxMedical|2025-12-12T19:03:58-05:00April 5, 2023|2023 Shareholder News, J-Plasma, Renuvion|
RENUVION WINS ADDY AWARD FOR #THISISME CAMPAIGNBy ApyxMedical|2025-12-12T19:04:30-05:00March 27, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2023 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T19:05:09-05:00March 16, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO COAGULATE AND CONTRACT SOFT TISSUES, INCLUDING SUBCUTANEOUS TISSUE, WHERE NEEDEDBy ApyxMedical|2025-12-12T19:05:39-05:00February 27, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES NEW FIVE-YEAR CREDIT AGREEMENT WITH MIDCAP FINANCIALBy ApyxMedical|2025-12-12T19:06:56-05:00February 21, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL RESULTS ON MARCH 16, 2023By ApyxMedical|2025-12-12T19:07:24-05:00February 16, 2023|2023 Shareholder News, J-Plasma, Renuvion|
RENUVION COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON ‘THE BALANCING ACT’ TALK SHOW ON LIFETIME FEBRUARY 13By ApyxMedical|2025-12-12T19:07:54-05:00February 9, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF THE RENUVION APR HANDPIECE FOR THE COAGULATION OF SUBCUTANEOUS SOFT TISSUES WHERE NEEDED, FOLLOWING LIPOSUCTIONBy ApyxMedical|2025-12-12T19:08:24-05:00February 1, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION LAUNCHES NEW ‘APYX ONE CONSOLE’ FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATESBy ApyxMedical|2025-12-12T19:10:24-05:00January 25, 2023|2023 Shareholder News, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:11:04-05:00January 10, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVIONBy ApyxMedical|2025-12-12T19:11:47-05:00January 3, 2023|2023 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER SANDLER 34TH ANNUAL HEALTHCARE CONFERENCEBy ApyxMedical|2025-12-12T19:12:19-05:00November 22, 2022|2022 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T19:12:51-05:00November 10, 2022|2022 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS ON NOVEMBER 10, 2022By ApyxMedical|2025-12-12T19:13:25-05:00September 26, 2022|2022 Shareholder News, J-Plasma, Renuvion|
‘BOTCHED’ TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURESBy ApyxMedical|2025-12-12T19:13:52-05:00September 13, 2022|2022 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE LAKE STREET BEST IDEAS GROWTH CONFERENCEBy ApyxMedical|2025-12-12T19:14:14-05:00September 6, 2022|2022 Shareholder News, J-Plasma, Renuvion|
